Patent Assignment
Reel/Frame 017480/0242
Change of Name
Recorded: 2006-04-17
Pages: 4
Assignor
PROTEIN DESIGN LABS, INC.
Executed: 2006-01-09
Assignee
PDL BIOPHARMA, INC.
34801 CAMPUS DRIVE, FREMONT, CALIFORNIA, 94555
Covered Properties
(4)
Methods of Diagnosing Breast Cancer
Patent:
6,762,020 →
Application:
09/642,034 →
Novel Methods of Diagnosing Breast Cancer, Compositions, and Methods of Screening for Breast Cancer Modulators
Patent:
6,649,342 →
Application:
09/657,960 →
Methods of Diagnosing Breast Cancer
Patent:
6,780,586 →
Application:
09/702,216 →
Compositions against cancer antigen LIV-1 and uses thereof
Application:
10/769,612 →
Publication:
US 2004/0141983
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 10, 2003
From: EOS BIOTECHNOLOGY, INC.
To: PROTEIN DESIGN LABS, INC.
Reel/Frame 014787/0675 →
Assignment of Assignor's Interest
Dec 22, 2003
From: EOS BIOTECHNOLOGY, INC.
To: PROTEIN DESIGN LABS, INC.
Reel/Frame 014837/0794 →
Assignment of Assignor's Interest
Sep 19, 2005
From: LAW, DEBBIE; GISH, KURT C.; MURRAY, RICHARD; CULP, PATRICIA
To: PROTEIN DESIGN LABS, INC.
Reel/Frame 016554/0803 →
Merger
Apr 17, 2006
From: EOS BIOTECHNOLOGY, INC.
To: PROTEIN DESIGN LABS, INC.
Reel/Frame 017480/0201 →
Assignment of Assignor's Interest
Mar 4, 2009
From: PDL BIOPHARMA, INC.
To: FACET BIOTECH CORPORATION
Reel/Frame 022343/0256 →
Change of Name
Dec 9, 2010
From: FACET BIOTECH CORPORATION
To: ABBOTT BIOTHERAPEUTICS CORP.
Reel/Frame 025483/0591 →
Change of Name
Feb 18, 2013
From: ABBOTT BIOTHERAPEUTICS CORP
To: ABBVIE BIOTHERAPEUTICS INC.
Reel/Frame 029825/0070 →